Moderna (MRNA) EBIT Growth (1y) (2018 - 2026)
Moderna (MRNA) EBIT Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moderna | 22.52 Bn | 17.32 Bn | -566.00 Mn | -32.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.19% |
| Dec 31, 2025 | 31.22% |
| Sep 30, 2025 | -271.43% |
| Jun 30, 2025 | 33.46% |
| Mar 31, 2025 | 17.06% |
| Dec 31, 2024 | -20,866.67% |
| Sep 30, 2024 | 96.52% |
| Jun 30, 2024 | 27.00% |
| Mar 31, 2024 | -245.90% |
| Dec 31, 2023 | -99.62% |
| Sep 30, 2023 | -272.56% |
| Jun 30, 2023 | -176.30% |
| Mar 31, 2023 | -108.66% |
| Dec 31, 2022 | -70.79% |
| Sep 30, 2022 | -67.23% |
| Jun 30, 2022 | -20.08% |
| Mar 31, 2022 | 233.89% |
| Dec 31, 2021 | 2,067.27% |
| Sep 30, 2021 | 1,614.04% |
| Jun 30, 2021 | 2,609.84% |